Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Brandy M Snider

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
The Prostate|April 19, 2016
Coordinated induction of cell survival signaling in the inflamed microenvironment of the prostateDavid W McIlwain, Marloes Zoetemelk, Jason D Myers, et al.
Molecular Metabolism|November 29, 2021
Anorectic and aversive effects of GLP-1 receptor agonism are mediated by brainstem cholecystokinin neurons, and modulated by GIP receptor activationAlessia Costa, Minrong Ai, Nicolas Nunn, et al.
Diabetes|May 2, 2022
GIPR Agonism Inhibits PYY-Induced Nausea-Like BehaviorRicardo J Samms, Richard Cosgrove, Brandy M Snider, et al.
Science Translational Medicine|December 18, 2024
The pharmacological basis for nonpeptide agonism of the GLP-1 receptor by orforglipronKyle W Sloop, Amy L Cox, David B Wainscott, et al.
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
The Prostate|April 19, 2016
Coordinated induction of cell survival signaling in the inflamed microenvironment of the prostateDavid W McIlwain, Marloes Zoetemelk, Jason D Myers, et al.
Molecular Metabolism|November 29, 2021
Anorectic and aversive effects of GLP-1 receptor agonism are mediated by brainstem cholecystokinin neurons, and modulated by GIP receptor activationAlessia Costa, Minrong Ai, Nicolas Nunn, et al.
Diabetes|May 2, 2022
GIPR Agonism Inhibits PYY-Induced Nausea-Like BehaviorRicardo J Samms, Richard Cosgrove, Brandy M Snider, et al.
Science Translational Medicine|December 18, 2024
The pharmacological basis for nonpeptide agonism of the GLP-1 receptor by orforglipronKyle W Sloop, Amy L Cox, David B Wainscott, et al.
Pageof 1